Dr. Tasannuma Ahsan is a physician and clinical researcher specializing in translational cancer research, precision oncology, biomarker analysis, and digital pathology. She holds an MBBS degree along with an MSc in Cancer Research and Precision Oncology from the University of Glasgow, UK. Her expertise bridges clinical medical practice, biomarker-driven study workflows, digital pathology quantification, and clinical data management aligned with NHS research governance and international quality frameworks.

In her capacity as Clinical & Precision Oncology Advisor at Novira Life Sciences, Dr. Ahsan provides strategic clinical oversight, protocol alignment, and regulatory advice to support clinical trial operations, biostatistics workflows, and precision medicine initiatives across the UK, EU, and international jurisdictions.

Dr. Ahsan completed her clinical research at the Queen Elizabeth University Hospital (NHS) and the University of Glasgow, where her work focused on investigating biomarker expression in colorectal polyps using multiplex immunofluorescence, QuPath digital pathology software, and statistical data analysis in SPSS. Her clinical background includes serving as a Medical Officer supporting pharmaceutical clinical trial operations—ensuring participant safety assessments, source documentation accuracy, and strict protocol compliance—alongside extensive rotating internship experience across primary, emergency, and internal medicine disciplines.

In addition to her clinical and research background, Dr. Ahsan brings significant experience in academic assessment governance and regulatory compliance within the UK higher education sector. Her work includes managing medical assessment logistics, maintaining secure institutional digital records under GDPR regulations, and supporting compliance with General Medical Council (GMC) standards and ALCOA+ data integrity principles.